Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 12Completed 9Not yet recruiting 3Unknown 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 267Prostatic Neoplasms 144Neoplasms 139Lung Neoplasms 84Colorectal Neoplasms 61Motor Activity 55Uterine Cervical Neoplasms 44Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 35Head and Neck Neoplasms 34Colonic Neoplasms 34Ovarian Neoplasms 33Brain Neoplasms 32Carcinoma, Hepatocellular 27Neoplasm Metastasis 26Rectal Neoplasms 24Stomach Neoplasms 22Melanoma 19Hematologic Neoplasms 19Endometrial Neoplasms 19Liver Neoplasms 18Anxiety Disorders 18Kidney Neoplasms 16Glioma 16Squamous Cell Carcinoma of Head and Neck 15Papillomavirus Infections 15Fatigue 15Esophageal Neoplasms 15Obesity 14Multiple Myeloma 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Genetic Predisposition to Disease × Clear all
NCT04774445 2025-02-10

MyCancerGene

Abramson Cancer Center at Penn Medicine

Phase NA Active not recruiting
400 enrolled

Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡